In the research chemical market, there are a lot of grifters who are not spending money on the things they should be doing when they manufacture. According to the NIH, BPC-157 demonstrates therapeutic potential across a broad range of musculoskeletal injuries through its angiogenic, anti-inflammatory, cytoprotective and tissue-regenerative properties However, despite this promise, and growing interest in athletic and online communities, human data is exceedingly sparse. As of August 2025, only three pilot studies had been conducted on the human use of BPC-157
GLP-1 medications tend to lower BP with weight loss
This anatomical distinction suggests that GIPRAs and GLP-1RAs act on different neuronal circuits, and their signals may be integrated within the brain, leading to synergistic anti-obesity effects
The study mentioned above, published in November of 2023, analyzed 12,136 comments on Reddit, 17,059 TikTok videos, and 14,515 Youtube videos mentioning certain GLP-1 receptor agonists (including Ozempic), finding the most common matches (620) related to insomnia and sleep problems
